Munich Startup: What problem do you solve?
Sebastian Blum, Founder: Interval Hypoxic-Hyperoxic Training, or IHHT for short, is a method where you lie down completely relaxed and alternate between breathing oxygen-poor and oxygen-rich air – essentially a trip to the mountains without leaving the sofa. Medical practices, physical therapy clinics, gyms, biohacking centers, and wellness hotels offer this for things like recovery, performance, and general well-being.
The devices used for this, known as hypoxicators, do their job well. Everything around them, however, remained pretty analog for a long time: programs are entered directly on the machine, readings like oxygen saturation and heart rate end up on paper or in a spreadsheet at best, and anyone supervising multiple clients at the same time is constantly running from bed to bed. That’s exactly where we come in. Respio is the software that connects the hypoxicator to the cloud: schedule programs, monitor sessions live, analyze and document results. Everything in one place, from a tablet or laptop. That saves time, makes the treatment safer, and ensures you finally see what’s actually happening in the body.
Munich Startup: What can only you do as of today?
Sebastian Blum: Respio doesn’t just read data; it is directly connected to the device. Via our Live View, a team can see in real time how everyone is doing during the session: oxygen saturation, pulse, the progression of each phase. If necessary, you can intervene immediately, adjust the oxygen concentration, or start and stop a session – even from the next room. In biofeedback mode, the oxygen supply continuously adapts to the individual’s vitals, instead of stubbornly sticking to a rigid protocol.
After each session, there is an evaluation—for example, our “SpO2 deficit” metric. It shows how much the body was challenged and how it adapts over weeks. And because Wi-Fi in a practice isn’t always as stable as one would like, Respio also works offline: the session continues as normal and syncs as soon as the connection is restored. More than 200 facilities now offer IHHT with Respio, and this spring we already took the second generation of our platform live with Respio-Cloud V2.
From Personal Training Experience to Business Idea
Munich Startup: What was the catalyst for founding the company?
Sebastian Blum: The short answer: I’m an IHHT fan myself. Since 2019, I’ve been doing IHHT three times a week and am convinced that it benefits everyone. On top of that, I love processes: with Sblum, we’ve been digitizing precisely those workflows that are analog, cumbersome, or simply poor since 2009. And anyone who regularly lies on the treatment bed themselves quickly realizes how much around the application is still done with pen and paper. That’s when it clicked for me.
Technically, we already had a strong foundation: since 2020, we at Sblum had been working in a research project to analyze vital signs using machine learning and derive decisions from them. That was a perfect fit for the hypoxication devices, which constantly deliver measurement data that hardly anyone makes use of. At some point it became clear: this is no longer just a small project, but an independent product that needs its own company and its own accountability, especially in the healthcare sector. So in July 2024, I founded Respio GmbH and gave the whole venture its own home.
Munich Startup: Was there ever a moment when you thought about giving up?
Sebastian Blum: Not throwing in the towel, but there were definitely phases where we asked ourselves whether we had taken on too much. The hardest moment was realizing that we had to rebuild large parts of our initial solution. The requirements had changed so drastically that patching things up no longer made sense. So we fundamentally overhauled both our code structure and business model once again. That hurts when you’re working without investor money and self-funding every single hour.
On top of that, software that interfaces with a medical device is no weekend project. Regulatory compliance, coordination with hardware manufacturers, data security—all of that takes time. What keeps us going is the feedback from the practices and studios. When someone tells us that, thanks to the live view, they can finally monitor multiple clients at the same time with ease, you remember exactly what you’re doing all this for.
Respio aims to become the standard in interval altitude training
Munich Startup: How will you know in a year’s time that you’re on the right track?
Sebastian Blum: We have a few pretty clear benchmarks for that. First: Respio should become the standard for facilities offering IHHT, as natural as the POS system at reception. When new providers no longer ask whether they need software, but only how quickly they can get started with Respiro, we’ll know we’re on the right track.
Second: We also want to place the platform on a solid regulatory foundation, keyword European Medical Device Regulation. That’s a lot of work, but it opens doors to clinics and practices that are still hesitant today. Third: Internationalization. Demand from abroad is there, and we want to take Respio beyond the DACH region step by step. And fourth, with a true bootstrapped mindset: If we can manage all of this out of our own revenue while maintaining a healthy pace, we’re doing a lot of things right.
Would you start up in Munich again, and why?
Sebastian Blum: Absolutely. Munich is home for us: Sblum is based here, our team is based here, and so is the network we’ve built over the years. On top of that, the city is a really great fit for a topic like ours. There’s a strong medical technology and health scene, an incredible number of sports and wellness offerings, and people who are open to new approaches when it comes to recovery and performance.
And then, of course, there’s the thing with the mountains. I enjoy skiing in my free time, and the Alps are just an hour away. At the same time, we’re building software so people can get high-altitude air on the ground floor right in the middle of the city. If that’s not a match, what is? The only downside: Good developers are in high demand in Munich, and rents don’t make it any easier either. But that’s a tradeoff we’re happy to make.
“We set our own pace”
Munich Startup: Bootstrapping or venture capital?
Sebastian Blum: Definitely bootstrapping, and that’s how it should stay. Respio has been self-funded from day one. Our model is simple: one subscription per device. But that also means we only build what customers really need and are willing to pay for. Every feature has to earn its place, and we notice very quickly if we’re heading down the wrong path.
We think that’s especially important in the healthcare sector. We don’t want to be forced to grow at all costs just because the next funding round is due in 18 months. Our customers rely on their software still being around in five years, and on decisions being driven by product and security rather than exit logic. Sure, with venture capital we might be faster in some areas. But we still managed to get Version 2 of the Respio Cloud on the road, and we’re pretty proud of that. We set our own pace, and that feels right.











